Juventas Therapeutics is a privately held biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. The company's lead product, Stromal–cell Derived Factor 1 (SDF–1), has been shown to protect and repair tissue following organ–damage in a broad range of pre–clinical disease models. Juventas is currently initiating a number of clinical studies to test therapy efficiency in different diseases.

We thank you for your patience as we update our website.

For inquiries related to clinical trials or investment opportunities please reach us at 216-273-4000 or info@juventasinc.com.

Our new corporate offices are located at:
3615 Superior Avenue, Suite 4403C
Cleveland, Ohio 44114